Inclusion and Exclusion Criteria

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Inclusion and Exclusion Criteria

Inclusion and Exclusion Criteria in Clinical Trials – CRO Full Service

Clinical trials are essential in the process of bringing new medications, therapies, and treatments to the market. The success of a clinical trial depends on the identification of suitable patients who meet specific criteria, known as inclusion and exclusion criteria.

Inclusion criteria are factors that must be present for a patient to participate in a clinical trial, while exclusion criteria are factors that prohibit a patient from participating in a trial. This blog will explore the importance of inclusion and exclusion criteria in clinical trials and their impact on the trial’s success.

Inclusion criteria in clinical trials:

Inclusion criteria are the set of characteristics that determine if a patient is suitable for participation in a clinical trial.

These criteria can vary depending on the nature of the trial, and it is important to have them clearly defined to ensure that the trial participants are representative of the target population. Inclusion criteria can be based on a patient’s age, gender, medical history, disease severity, or other factors.

One of the most important factors to consider when defining inclusion criteria is the disease or condition being studied. For example, if a clinical trial is studying a new drug for the treatment of breast cancer, it would be essential to include only those patients who have been diagnosed with breast cancer.

The inclusion criteria may also include the stage of cancer, the presence of specific markers or genetic mutations, and the previous treatment history of the patient.

Another important factor to consider when defining inclusion criteria is the patient’s overall health status. The trial may require participants to have specific vital signs, laboratory values, or other health indicators within a certain range. This ensures that the study results are not skewed by factors unrelated to the treatment being studied.

Exclusion criteria in clinical trials:

Exclusion criteria are factors that prohibit a patient from participating in a clinical trial. These criteria are essential to ensure that the study results are not affected by factors unrelated to the treatment being studied. Exclusion criteria can be based on a patient’s medical history, current health status, or other factors that may impact the study results.

One of the most common exclusion criteria in clinical trials is the use of certain medications. Patients who are taking medications that may interact with the treatment being studied may be excluded from participating in the trial. Additionally, patients who have a history of allergic reactions or adverse reactions to specific medications may also be excluded.

Inclusion and Exclusion Criteria

Inclusion and Exclusion Criteria

Patients who have underlying medical conditions that may impact the study results may also be excluded from participating in the trial. For example, if a clinical trial is studying the effectiveness of a new drug for the treatment of heart disease, patients with a history of liver disease or kidney disease may be excluded.

This is because these underlying medical conditions may impact the patient’s response to the treatment being studied.

The importance of inclusion and exclusion criteria in clinical trials:

Inclusion and exclusion criteria are essential in clinical trials because they ensure that the study results are accurate and applicable to the target population. By carefully selecting study participants based on specific criteria, researchers can ensure that the study results are not influenced by factors unrelated to the treatment being studied.

Additionally, inclusion and exclusion criteria ensure that the safety of study participants is protected. For example, excluding patients who have a history of adverse reactions to specific medications helps to reduce the risk of adverse events during the study.

Inclusion and exclusion criteria also play an important role in the recruitment of study participants. By clearly defining the criteria, researchers can identify suitable candidates and reduce the risk of enrolling patients who may not be appropriate for the study.

However, it is important to note that inclusion and exclusion criteria may also create limitations in the interpretation of study results. By selecting a specific subset of the target population, the study results may not be applicable to the broader population.

Therefore, it is essential to carefully consider the inclusion and exclusion criteria to ensure that the study results are both accurate and applicable.

Inclusion and Exclusion Criteria

Welcome to Cohortias!

The CRO
of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Inclusion and Exclusion Criteria

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Inclusion and Exclusion Criteria

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Inclusion and Exclusion Criteria

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Inclusion and Exclusion Criteria

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.

CLINICAL DEVELOPMENT

  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development

CLINICAL TRIAL SERVICES

Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards

MAIN THERAPEUTIC AREAS

  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Inclusion and Exclusion Criteria

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Inclusion and Exclusion Criteria

We provide our services with offices in:

Argentina,
Brazil,
Colombia &
Mexico.

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Inclusion and Exclusion Criteria

The Cohortias Team

Inclusion and Exclusion Criteria

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Inclusion and Exclusion Criteria

Network & Partnerships